Clinical trials
Recruiting Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ascentage Pharma Group Inc. | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| King Faisal Specialist Hospital & Research Center | 1 |
| Martin Schrappe | 1 |
| Mats Heyman | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Novartis Pharmaceuticals | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
| University Hospital Muenster | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 |
| Burkitt Lymphoma | 1 |
| Leukemia | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Pathologic Complete Response | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.